linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Adani Enterprises Ltd.
 
Source DateBoard Meeting DateDetails
06 Nov 202511 Nov 2025 Right Issue of Equity Shares
28 Oct 202504 Nov 2025 Quarterly Results
06 Oct 202508 Oct 2025 Inter-alia to consider and approve the proposal of fund raising by way of issuance of debt securities through permissible modes, including but not limited to a private placement or Public Issue or a qualified institutions placement, preferential issue, or any other method or combination of methods as may be permitted under applicable laws, in one or more tranche or tranches, subject to such regulatory or statutory approvals as may be required.
28 Jul 202531 Jul 2025 Quarterly Results
28 Apr 202501 May 2025 Audited Results & A.G.M. & Final Dividend
24 Jan 202530 Jan 2025 Quarterly Results
22 Oct 202429 Oct 2024 Quarterly Results
26 Jul 202401 Aug 2024 Quarterly Results
23 May 202428 May 2024 Inter alia, to consider the Proposal of Raising of Funds
25 Apr 202402 May 2024 Audited Results & Final Dividend
24 Jan 202401 Feb 2024 Quarterly Results
25 Oct 202302 Nov 2023 Quarterly Results
27 Jul 202303 Aug 2023 Quarterly Results
10 May 202313 May 2023 Interalia, to consider and approve the proposal of raising of funds by way of issuance equity shares or any other eligible securities (?Securities?) through permissible modes, including but not limited to a private placement, a qualified institutions placement, preferential issue, or any other method or combination of methods as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required and the approval of shareholders of the Company.
27 Apr 202304 May 2023 Audited Results & Dividend
07 Feb 202314 Feb 2023 Quarterly Results
22 Nov 202225 Nov 2022ADANI ENTERPRISES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/11/2022 ,inter alia, to consider and approve the proposal of raising of funds by way of further public offering, preferential allotment (including a qualified institutions placement or through any other permissible mode) and/or combination thereof as may be considered appropriate, by way of issue of equity shares or any other eligible securities.
25 Oct 202203 Nov 2022 Quarterly Results
28 Jul 202204 Aug 2022 Quarterly Results & Inter alia, to consider Fund raising by way of issuance of debt securities.
26 Apr 202203 May 2022 Final Dividend & Audited Results
Page 1 of 6
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.